Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines
The development of vaccines, especially RNA-based, directed against patient-specific tumor neoepitopes is an active and productive area of cancer immunotherapy. Promising clinical results in melanoma and other solid tumor types are emerging. As with all cancer therapy modalities, neoepitope vaccine...
Saved in:
| Main Authors: | Renee N Donahue, Jeffrey Schlom, James L Gulley, James W Hodge, Claudia Palena, Duane H Hamilton, Sofia R Gameiro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-07-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/7/e009595.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control
by: Renee N Donahue, et al.
Published: (2025-05-01) -
Cancer therapy via neoepitope-specific monoclonal antibody cocktails
by: Colin J. Hartman, et al.
Published: (2025-05-01) -
A lentiviral vector targeting a KRAS neoepitope for cancer immunotherapy
by: Anastasia Goloudina, et al.
Published: (2025-07-01) -
Comparative performance analysis of neoepitope prediction algorithms in head and neck cancer
by: Leila Y. Chihab, et al.
Published: (2025-03-01) -
Neoepitope BTLAP267L-specific TCR-T cell immunotherapy unlocks precision treatment for hepatocellular carcinoma
by: Fang Liu, et al.
Published: (2025-04-01)